Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease

European Journal of Nuclear Medicine

Volumn 29, Issue 10, 2002, Pages 1349-1356

  Yamauchi, Hiroshi ^a   Okazawa, Hidehiko ^a   Kishibe, Yoshihiko ^a   Sugimoto, Kanji ^a   Takahashi, Masaaki ^a  

^a Shiga Medical Center   (Japan)

Author keywords

Acetazolamide; Carotid artery disease; Cerebral blood flow; Cerebral oxygen metabolism; Positron emission tomography

Indexed keywords

ACETAZOLAMIDE; DIAGNOSTIC AGENT; OXYGEN;

ARTICLE; BLOOD FLOW VELOCITY; BRAIN; BRAIN CIRCULATION; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; CEREBRAL ARTERY DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; VALIDATION STUDY; VASODILATATION; ADULT; AGED; BLOOD VOLUME; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; OCCLUSIVE CEREBROVASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; ARTERY OCCLUSION; BRAIN METABOLISM; ISCHEMIA;

ACETAZOLAMIDE; ARTERIAL OCCLUSIVE DISEASES; BLOOD FLOW VELOCITY; BRAIN; CAROTID ARTERY THROMBOSIS; CAROTID STENOSIS; CEREBRAL ARTERIAL DISEASES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN; OXYGEN CONSUMPTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATION;

EID: 0036383479     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0899-x     Document Type: Article

References (27)

1. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol 1991; 29:231-240.
2. Vorstrup S. Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand Suppl 1988; 114:1-48.
3. Yonas H, Pindzola RR. Physiological determination of cerebrovascular reserves and its use in clinical management. Cerebrovasc Brain Metab Rev 1994; 6:325-340.
4. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW. Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 1993; 79:483-489.
5. Webster MW, Makaroun MS, Steed DL, Smith HA, Johnson DW, Yonas H. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg 1995; 21:338-344.
6. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke 2001; 32:2110-2116.
7. Derdeyn CP, Grubb RL Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology 1999; 53:251-259.
8. Demolis P, Florence G, Thomas L, Tran Dinh Y, Giudicelli J, Seylaz J, Alkayed N. Is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation? An experimental study. Stroke 2000; 31:508-515.
9. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol 1995;16:563-570.
10. Gotoh F, Meyer JS, Tomita M. Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Arch Intern Med 1966; 117:39-46.
11. Sette G, Baron J, Mazoyer B, Levasseur M, Pappata S, Crouzel C. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Brain 1989; 112:931-951.
12. Yamauchi H, Fukuyama H, Kimura J. Hemodynamic and metabolic changes in crossed cerebellar hypoperfusion. Stroke 1992; 23:855-860.
13. DeGardo T, Turkington T, Williams J, Stearns C, Hoffmann J, Coleman R. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35:1398-1406.
14. 15O gas and water. J Cereb Blood Flow Metab 2001; 21:793-803.
15. Votaw JR, Shulman SD. Performance evaluation of the Pico-Count flow-through detector for use in cerebral blood flow PET studies. J Nucl Med 1998; 39:509-515.
16. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 2001; 21:1472-1479.
17. 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr 1980; 4:727-736.
18. Lammertsma AA, Jones T. Correction for the presence of intravascular oxygen-15 in the steady-state technique for measuring regional oxygen extraction ratio in the brain. 1. Description of the method. J Cereb Blood Flow Metab 1983; 3:416-424.
19. Gibbs JM, Wise RJS, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet 1984; 1:310-314.
20. Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med 1983; 24:782-789.
21. Raichle ME, Martin WRW, Herscovitch P, Mintun MA, Markham J. Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med 1983; 24:790-798.
22. 15O PET to distinguish cerebral perfusion from blood volume. J Nucl Med 2001; 42:1032-1039.
23. Kretschmann HJ, Weinrich W. Neuroanatomy and cranial computed tomography. New York: Thieme-Stratton; 1986:70-74.
24. Yamauchi H, Fukuyama H, Kimura J, Konishi J, Kameyama M. Hemodynamics in internal carotid artery occlusion examined by positron emission tomography. Stroke 1990; 21:1400-1406.
25. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke 1996; 27:761-765.
26. Lassen NA, Losen TS, Højgaard K, Skriver E. Incomplete infarction: a CT-negative irreversible ischemic brain lesion. J Cereb Blood Flow Metab 1983; 3(Suppl 1):S602-S603.
27. Feeney DM, Baron JC. Diaschisis. Stroke 1986; 17:817-830.